Gosselin, L., Vilcu, A., Souty, C., Steichen, O., Launay, T., Conte, C., . . . Rossignol, L. (2023). Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the French healthcare insurance database. European Journal of Clinical Pharmacology, 79(7), 937-946.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Gosselin, Laëtitia, et al. "Prevalence and Bleeding Risk Associated with the Concomitant Use of Direct Oral Anticoagulants and Antiarrhythmic Drugs in Patients with Atrial Fibrillation, Based on the French Healthcare Insurance Database."
European Journal of Clinical Pharmacology 79, no. 7 (2023): 937-946.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Gosselin, Laëtitia, et al. "Prevalence and Bleeding Risk Associated with the Concomitant Use of Direct Oral Anticoagulants and Antiarrhythmic Drugs in Patients with Atrial Fibrillation, Based on the French Healthcare Insurance Database."
European Journal of Clinical Pharmacology, vol. 79, no. 7, 2023, pp. 937-946.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.